Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank Verwiel currently holds 13,300 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Verwiel has been a net seller of NTLA stock. They have purchased $0 and sold $37.6K worth of shares.
Frank Verwiel's most recent insider trade was on Jun 9, 2026, when they sold 13,300 shares at $0.00 per share.
Frank Verwiel serves as Executive at Intellia Therapeutics, Inc. (NTLA). They have executed 15 insider transactions totaling $37.6K over their tenure at the company.
Frank Verwiel holds the position of Executive at Intellia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Frank Verwiel has shown a selling trading pattern, with $0 in total purchases and $37.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Frank Verwiel was on Sep 29, 2014, when they sold $719.6K worth of ITMN shares. This transaction involved 9,725 shares at $74.00 per share.
Frank Verwiel currently owns 13,300 shares of Intellia Therapeutics, Inc. (NTLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank Verwiel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank Verwiel has 15 Form 4 filings on record as an insider at Intellia Therapeutics, Inc..
Set alerts for Frank Verwiel and 40,000+ other insiders.